BAC
47
5
CVX
25
3
IFF
59
5
AVGO
40
-14
INTC
41
-6
BRK.B
42
2
MCHP
49
-3
PM
60
8
EMR
50
2
BA
45
3
GRMN
61
2
SRCL
54
-13
BK
66
3
JBHT
42
4
AVB
72
2
TGT
45
3
SYY
57
4
KEY
39
6
AAP
26
2
XEL
51
3
BAC
47
5
CVX
25
3
IFF
59
5
AVGO
40
-14
INTC
41
-6
BRK.B
42
2
MCHP
49
-3
PM
60
8
EMR
50
2
BA
45
3
GRMN
61
2
SRCL
54
-13
BK
66
3
JBHT
42
4
AVB
72
2
TGT
45
3
SYY
57
4
KEY
39
6
AAP
26
2
XEL
51
3
Financhill
Back

Reliance Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
37

RS
Reliance

Last Price:
280.06
Seasonality Move:
-1.57%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.82
Seasonality Move:
-0.9%
Sell
37
Reliance (RS) is a Sell

Is Reliance a Buy, Sell or Hold?

  • The current Reliance [RS] share price is $280.03. The Score for RS is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • RS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.82. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RS Stock Price Chart

What is Reliance's stock price today?

  • The Reliance share price today is $280.03
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RS is experiencing slight selling pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.82
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing slight buying pressure.

RS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.01 Sell
Relative Strength Index (14 RSI): 37.58 Sell
Chaikin Money Flow: -74289 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (281.01 - 299.39) Sell
Bollinger Bands (100): (289.63 - 326.21) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.7 Sell
Relative Strength Index (14 RSI): 46.74 Sell
Chaikin Money Flow: 84619 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.82 - 42.02) Sell
Bollinger Bands (100): (40.86 - 48.8) Sell

RS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 281.16 Sell
20-day SMA: 287.01 Sell
50-day SMA: 295.73 Sell
200-day SMA: 288.22 Sell
8-day EMA: 282 Sell
20-day EMA: 286.24 Sell
50-day EMA: 294.71 Sell
200-day EMA: 289.25 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.53 Buy
20-day SMA: 40.36 Sell
50-day SMA: 41.57 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.71 Buy
20-day EMA: 40.38 Sell
50-day EMA: 41.84 Sell
200-day EMA: 43.38 Sell

Reliance Earnings Growth & RS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.33 per share, an increase next quarter of $0.14 per share, a decrease this year of $2.88 per share, and an increase next year of $0.74 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

Reliance Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):